Actelion (Actelion) Change In Inventory : $-34 Mil (TTM As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Change In Inventory?

Actelion's change in inventory for the quarter that ended in Mar. 2017 was $3 Mil. It means Actelion's inventory declined by $3 Mil from Dec. 2016 to Mar. 2017 .

Actelion's change in inventory for the fiscal year that ended in Dec. 2016 was $-72 Mil. It means Actelion's inventory increased by $72 Mil from Dec. 2015 to Dec. 2016 .

Actelion's Total Inventories for the quarter that ended in Mar. 2017 was $132 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Actelion's Days Inventory for the quarter that ended in Mar. 2017 was 185.55.

Inventory Turnover measures how fast the company turns over its inventory within a year. Actelion's Inventory Turnover for the quarter that ended in Mar. 2017 was 0.49.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Actelion's Inventory-to-Revenue for the quarter that ended in Mar. 2017 was 0.21.

Actelion Change In Inventory Historical Data

The historical data trend for Actelion's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Change In Inventory Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Change In Inventory

Get a 7-Day Free Trial

8.07

3.78

-7.60

-1.62

-72.36

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Change In Inventory	Get a 7-Day Free Trial															-37.18	-23.16	0.64	-15.17	3.33

Actelion Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-34 Mil.

Actelion (OTCPK:ALIOF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Actelion's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	132.8035	/	65.309	*	365 / 4
	=	185.55

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Actelion's Inventory Turnover for the quarter that ended in Mar. 2017 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	65.309	/	132.8035
	=	0.49

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Actelion's Inventory to Revenue for the quarter that ended in Mar. 2017 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	132.8035	/	645.285
	=	0.21

Actelion Change In Inventory Related Terms

Thank you for viewing the detailed overview of Actelion's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (Actelion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 02-14-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson • 08-03-2016

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 01-24-2017

Actelion Still On Growth Track

By reports.droy reports.droy • 02-18-2015